Avant Diagnostics Inc (AVDX) - Product Pipeline Analysis, 2019 Update

Summary

Avant Diagnostics Inc (Avant Diagnostics) operates as a healthcare data generating technology company that provides biomarker testing services that are being planned or developed in multiple areas of oncology. The company’s products include Theralink, a tumor biomarker platform that enables physicians to make personalized treatment recommendation for cancer patients and enables early and late state drug development for pharmaceutical and biotechnology companies. It also personalized medicine data through its TheraLink assays initially for breast cancer to assist clinical oncologists in identifying likely responders for over FDA-approved drug treatment regimens. Avant Diagnostics also develops phospho-proteomic technologies for measuring the activation status of key signaling pathways with applications across multiple cancer types such as breast, colorectal and pancreatic, that are instrumental in the development of companion diagnostics for molecular-targeted therapies. The company serves healthcare and medical care sectors. Avant Diagnostics is headquartered in Washington, D.C., the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Avant Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Avant Diagnostics Inc Company Overview
Avant Diagnostics Inc Company Snapshot
Avant Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Avant Diagnostics Inc – Pipeline Analysis Overview
Avant Diagnostics Inc - Key Facts
Avant Diagnostics Inc - Major Products and Services
Avant Diagnostics Inc Pipeline Products by Development Stage
Avant Diagnostics Inc Pipeline Products Overview
LymPro Test - TBI/CTE
LymPro Test - TBI/CTE Product Overview
OvaDx
OvaDx Product Overview
TheraLink Assay - Colorectal Cancer
TheraLink Assay - Colorectal Cancer Product Overview
TheraLink Assay - Non-Small Cell Lung Cancer
TheraLink Assay - Non-Small Cell Lung Cancer Product Overview
TheraLink Assay - Pancreatic Cancer
TheraLink Assay - Pancreatic Cancer Product Overview
Theralink mTOR Phosphoprotein Assay - Breast Cancer
Theralink mTOR Phosphoprotein Assay - Breast Cancer Product Overview
Avant Diagnostics Inc - Key Competitors
Avant Diagnostics Inc - Key Employees
Avant Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Avant Diagnostics Inc, Recent Developments
May 08, 2019: Avant Diagnostics corporate update
Apr 16, 2018: Amarantus Appoints Michael T. Ropacki, PhD as Chief Medical Advisor for Alzheimer''s Blood Diagnostic LymPro Test Program
Sep 27, 2017: Avant Diagnostics' Newly Appointed President & CEO Philippe Goix Provides Update to Shareholders
Jul 18, 2017: Avant Diagnostics Highlights Published Clinical Utility Data for Theralink mTOR Pathway Activation Data Predicting Tamoxifen and Other Endocrine Treatment Response in Estrogen Receptor Positive (ER+) Breast Cancer
Jun 27, 2017: Avant Diagnostics Announces Confirmatory Clinical Utility Data for Theralink in Pancreatic Cancer
Jun 21, 2017: Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink Tumor Biomarker Platform
Jun 14, 2016: Avant Diagnostics Presented Data on TheraLink Pancreatic Cancer Assay at the International Symposium on Pancreas Cancer 2016
May 19, 2016: Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting
Dec 15, 2015: Avant Diagnostics Announces Launch of New Corporate Website
Oct 07, 2015: Avant Diagnostics Receives FDA IRB Approval for OvaDx Ovarian Cancer Validation Test Specimens
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Avant Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Avant Diagnostics Inc Pipeline Products by Equipment Type
Avant Diagnostics Inc Pipeline Products by Indication
Avant Diagnostics Inc, Key Facts
Avant Diagnostics Inc, Major Products and Services
Avant Diagnostics Inc Number of Pipeline Products by Development Stage
Avant Diagnostics Inc Pipeline Products Summary by Development Stage
LymPro Test - TBI/CTE - Product Status
LymPro Test - TBI/CTE - Product Description
OvaDx - Product Status
OvaDx - Product Description
TheraLink Assay - Colorectal Cancer - Product Status
TheraLink Assay - Colorectal Cancer - Product Description
TheraLink Assay - Non-Small Cell Lung Cancer - Product Status
TheraLink Assay - Non-Small Cell Lung Cancer - Product Description
TheraLink Assay - Pancreatic Cancer - Product Status
TheraLink Assay - Pancreatic Cancer - Product Description
Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Status
Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Description
Avant Diagnostics Inc, Key Employees
Avant Diagnostics Inc, Subsidiaries
Glossary
List of Figures
Avant Diagnostics Inc Pipeline Products by Equipment Type
Avant Diagnostics Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook